💨 Abstract

Siemens Healthineers reported Q1 revenue slightly above expectations, with a 16% increase in U.S. revenues and a 6% decline in China due to delays in customer orders, likely due to a Chinese anti-corruption campaign. The company's adjusted EBIT also beat expectations. Despite this, the company confirmed its 2025 full-year revenue and EPS guidance.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖